Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Medical and Pediatric Oncology|December 4, 1998
Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemiaM F Ozkaynak, V I Avramis, S Carcich, et al.
Oncogene|October 11, 2001
Protein phosphatase 1alpha-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma proteinR H Wang, C W Liu, V I Avramis, et al.
Cancer Research|July 15, 1987
Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1B E Antonsson, V I Avramis, J Nyce, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantationA A Khan, J G Villablanca, C P Reynolds, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK geneS Wu, X Liu, M M Solorzano, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Preclinical pharmacology of the antitumor agent O-6-methylguanine in CDF1 miceV I Avramis, K K Chan, M M Solorzano, et al.
The American Journal of Pediatric Hematology/Oncology|November 1, 1993
Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acidJ G Villablanca, A A Khan, V I Avramis, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 1, 1997
Acute lymphoblastic leukaemia: a guide to asparaginase and pegaspargase therapyL J Ettinger, A G Ettinger, V I Avramis, et al.
In Vivo (Athens, Greece)|April 5, 2001
Synergistic antiviral effect of PEG-asparaginase (ONCASPAR), with protease inhibitor alone and in combination with RT inhibitors against HIV-1 infected T-cells: a model of HIV-1-induced T-cell lymphomaV I Avramis, R Kwock, I A Avramis, et al.
Anticancer Research|April 13, 2001
Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalitiesF Majlessipour, R Kwock, S Martin-Aragon, et al.
Pageof 5